Induction of a Novel Ca 2+ -Dependent Serine Protease in Rat Liver Treated with Various Promoters of Liver Carcinogenesis

Abstract

The induction of a novel Ca²⁺-dependent protease in rat liver treated with various liver promoters, as well as its increase in preneoplastic lesions during liver carcinogenesis, was demonstrated. Six groups of male Fischer 344 rats (150 g body weight) were fed separately diets containing one of the following promoters: 0.05% phenobarbital (PB), 0.05% dichlorodiphenyltrichloroethane (DDT), 0.25% ethyl-α-chlorophenoxyisobutyrate (CPIB), 0.5% butylated hydroxytoluene (BHT), 10 ppm 17-α-ethynylestradiol (EE), and 0.05% of the non-promoter diphenylhydantoin (DH). After feeding the indicated diets for 1 week, rats were killed and protease activity in the microsomal fraction of liver tissue was determined using N-benzoyl-L-tyrosine ethyl ester as substrate. The activity of protease increased 3- to 5-fold after treatment with the promoters and compared with normal liver; the non-promoter (DH) induced a slight increase in activity. Hyperplastic nodules were induced according to the method of Solt and Farber. The activity of protease was significantly high in these preneoplastic lesions compared with the surrounding liver tissue. Biochemical characterization of this protease revealed the following properties: 1) high Ca²⁺ dependency, 2) different molecular weight and optimum pH from previously reported proteases, and 3) preferential distribution in the SER fraction. These results suggest that a novel type of protease is induced specifically in the liver by promoters of liver carcinogenesis. The possible importance of this protease in the carcinogenic process is discussed.

References

1. Ashendel CL , Staller JM , and Boutwell RK (1983). Protein kinase activity associated with a phorbol ester receptor purified from mouse brain. Cancer Res. 43:4333–4337.

2. Becker FF (1981). Inhibition of spontaneous hepatocarcinogenesis in C3H/HeN mice by Edi Pro A, and isolated soy protein. Carcinogenesis 2:1213–1214.

3. Dallner G , Siekevitz P , and Palade GE (1966). Biogenesis of endoplasmic reticulum membranes. I. Structural and chemical differentiation in developing rat hepatocyte. J. Cell Biol. 30:73–96.

4. Hozumi M , Ogawa M , Sugimura T , Takeuchi T , and Umezawa H (1972). Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from actinomycetes. Cancer Res. 32:1725–1728.

5. Inoue M , Kishimoto A , Takai Y , and Nishizuka Y (1977). Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J. Biol. Chem. 252:7610–7616.

6. Kaneko A , Yoshida Y , Enomoto K , Kaku T , Hirata K , and Onoé T (1979). Induction of a microsomal butyrylesterase in rat liver by phenobarbital treatment. Biochim. Biophys. Acta 582:185–195.

7. Kennedy AR (1985). The conditions for the modification of radiation transformation in vitro by a tumor promoter and protease inhibitors. Carcinogenesis 6:1441–1445.

8. Kuroki T and Drevon C (1979). Inhibition of chemical transformation in C3H/10T1/2 cells by protease inhibitors. Cancer Res. 39:2755–2761.

9. Laemmli UK (1979). Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680–685.

10.

10. Nishizuka Y (1984). The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308:693–698.

11.

11. Sogawa K and Takahashi K (1978). Evidence for the presence of a serine proteinase(s) associated with the microsomal membranes of rat liver. J. Biochem. (Tokyo) 84:763–770.

12.

12. Solt DB and Farber E (1976). New principle for the analysis of chemical carcinogenesis. Nature 267: 702.

13.

13. Troll W , Klassen A , and Janoff A (1970). Tumorigenesis in mouse skin: Inhibition of synthetic inhibitors of proteases. Science 169:1211–1213.

14.

14. Troll W , Meyn MS , and Rossman TG (1978). Mechanisms of protease action in carcinogenesis. In: Mechanisms of Tumor Promotion and Cocarcinogenesis, Vol. 2, TJ Slaga , A Sivak , and RK Boutwell (eds). Raven Press, New York, pp. 301–312.

15.

15. Walsh KA and Wilcox PE (1970). Serine proteases. Methods Enzymol. 19:31–41.

16.

16. Wigler M and Weinstein IB (1976). Tumor promoter induces plasminogen activator. Nature 259:232–233.